ZVRA Past Earnings image   This ZVRA past earnings page last updated 4/1/2024
ZVRA Past Earnings
PeriodPast Earnings DateGAAP
Q4 20233/28/2024-0.400
Q3 202311/7/2023-0.400
Q2 20238/14/2023-0.150
Q1 20235/15/2023-0.340
Q4 20223/7/2023-0.260
Q3 202211/9/2022-0.190
Q2 20228/11/2022-0.190
Q1 20225/12/2022-0.050
Q4 20213/30/2022-0.080
Q3 202111/10/2021-0.060
Q2 20218/12/2021-0.400
Q1 20215/13/2021-1.610
FY 20203/11/2021-1.070
Q2 20208/12/20200.010
Q1 20205/12/2020-0.120
FY 20192/28/2020-0.180
Q3 201911/14/20190.060
Q2 20198/13/2019-0.330
Q1 20195/14/2019-0.460
Q4 20182/28/2019-0.21
Q3 201811/8/2018-0.94
Q2 20188/9/2018-0.91
Q1 20185/10/2018-1.77
Q4 20173/29/2018-0.72
Q3 201711/9/2017-0.68
Q2 20178/10/2017-0.44
Q1 20175/10/2017-0.84
Q4 20163/9/2017-0.68
Q3 201611/9/2016-0.92
Q2 20168/10/2016-0.58
Q1 20165/12/20160.12
Q4 20153/10/2016-0.64
Q3 201511/12/2015-0.68
Q2 20158/13/2015-2.45
Q1 20155/27/2015-2.5
ZVRA Past Revenue
PeriodPast Earnings DateGAAP
Q4 20233/28/20240.01B
Q3 202311/7/20230.00B
Q2 20238/14/20230.01B
Q1 20235/15/20230.00B
Q4 20223/7/20230.00B
Q3 202211/9/20220.00B
Q2 20228/11/20220.00B
Q1 20225/12/20220.00B
Q4 20213/30/20220.00B
Q3 202111/10/20210.00B
Q2 20218/12/20210.01B
Q1 20215/13/20210.01B
FY 20203/11/20210.00B
Q2 20208/12/20200.01B
Q1 20205/12/20200.00B
FY 20192/28/20200.00B
Q3 201911/14/20190.01B
Q2 20198/13/2019NA
Q1 20195/14/2019NA
Q4 20182/28/2019NA
Q3 201811/8/2018NA
Q2 20188/9/2018NA
Q1 20185/10/2018NA
Q4 20173/29/2018NA
Q3 201711/9/2017NA
Q2 20178/10/2017NA
Q1 20175/10/2017NA
Q4 20163/9/2017NA
Q3 201611/9/2016NA
Q2 20168/10/2016NA
Q1 20165/12/2016NA
Q4 20153/10/2016NA
Q3 201511/12/2015NA
Q2 20158/13/2015NA
Q1 20155/27/2015NA
Quotes delayed 20 minutes

Email EnvelopeFree ZVRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Zevra Therapeutics (ZVRA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ZY Past Earnings
ZYME Past Earnings
ZYNE Past Earnings
ZYXI Past Earnings
A Past Earnings
AADI Past Earnings
ABBV Past Earnings
ABC Past Earnings
ABEO Past Earnings
ABIO Past Earnings

ZVRA Past Earnings Q&A

What was the best and worst ZVRA past earnings results?
For Zevra Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ZVRA past earnings result in our data set was 0.12/share posted in Q1 2016, while the lowest was in Q1 2015 when ZVRA posted -2.5/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2023 when ZVRA reported 0.01B in revenue, while the quarter with the lowest revenue in our data set was Q2 2019 at NA of revenue.

  Suggested answer: There are 35 ZVRA past earnings results in our data set.

On this page we presented the ZVRA past earnings date information for Zevra Therapeutics. Reviewing that ZVRA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2016, when ZVRA posted gaap of 0.12/share. Meanwhile the lowest ZVRA past earnings result was in Q1 2015, when ZVRA posted gaap of -2.5/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2023 when ZVRA reported 0.01B in revenue, while the smallest revenue quarter was Q2 2019 when ZVRA reported NA in revenue.

Any self directed investor doing their due diligence on ZVRA or any other given stock can benefit from researching all of the Zevra Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Zevra Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ZVRA. Thanks for visiting, and the next time you need to research ZVRA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: NBB market cap history, APU YTD Return, SRCE Average Annual Return.

 

ZVRA Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.